|
GINS1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.57620000005043E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.68589999999447E-06 |
| Normal-vs-Stage2 |
3.335700E-02 |
| Normal-vs-Stage3 |
1.29680000005017E-06 |
| Normal-vs-Stage4 |
4.095300E-03 |
| Stage1-vs-Stage2 |
4.565900E-02 |
| Stage1-vs-Stage3 |
3.069400E-01 |
| Stage1-vs-Stage4 |
3.012800E-01 |
| Stage2-vs-Stage3 |
9.560700E-03 |
| Stage2-vs-Stage4 |
3.976600E-01 |
| Stage3-vs-Stage4 |
1.299960E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.94740000078764E-08 |
| Normal-vs-AfricanAmerican |
2.204500E-02 |
| Normal-vs-Asian |
6.158200E-04 |
| Caucasian-vs-AfricanAmerican |
5.399600E-01 |
| Caucasian-vs-Asian |
8.324100E-02 |
| AfricanAmerican-vs-Asian |
7.846800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.586200E-04 |
| Normal-vs-Female |
3.20180000001891E-06 |
| Male-vs-Female |
1.345980E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.89939999962041E-07 |
| Normal-vs-Age(41-60Yrs) |
3.039000E-04 |
| Normal-vs-Age(61-80Yrs) |
1.224320E-04 |
| Normal-vs-Age(81-100Yrs) |
1.457390E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.820300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.545000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.034200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.967200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.638800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.309200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.678560E-01 |
| Classical-VS-Follicular |
2.72270000001296E-06 |
| Classical-VS-Other |
2.908800E-01 |
| Classical-VS-Normal |
1.54560000020787E-07 |
| Tall-VS-Follicular |
6.02739999999713E-05 |
| Tall-VS-Other |
1.245850E-01 |
| Tall-VS-Normal |
1.40069999998715E-06 |
| Follicular-VS-Other |
6.442800E-01 |
| Follicular-VS-Normal |
1.466970E-01 |
| Other-VS-Normal |
2.576200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.82350999999858E-05 |
| Normal-vs-N1 |
1.284240E-03 |
| N0-vs-N1 |
9.184600E-01 |
|
|
